All lobbying filings

CROSSROADS STRATEGIES, LLC

CROSSROADS STRATEGIES, LLC filed a Q4 report for MADRIGAL PHARMACEUTICALS, INC. on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for MADRIGAL PHARMACEUTICALS, INC. · biopharmaceutical company

All filings by CROSSROADS STRATEGIES, LLC · Everything MADRIGAL PHARMACEUTICALS, INC. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to drug pricing; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Medicare/Medicaid

Issues related to CMMI Drug Pricing Demonstration Programs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.